The Global Non-melanoma Skin Cancer (NMSC) Market (2018-2022) by Type of NMSC, Therapy and Region - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 9, 2019--The “Global Non-melanoma Skin Cancer Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering.
The non-melanoma skin cancer market will register a CAGR of almost 6% by 2022.
The latest trend gaining momentum in the market is the high off-label use of topical treatments for NMSC.
According to the report, one of the major drivers for this market is the rising incidence of NMSC across the globe, especially in Europe, the US, and Australia.
Further, the report states that one of the major factors hindering the growth of this market is the low data availability on NMSC statistics in cancer registries.
Key PlayersBausch Health F. Hoffmann-La Roche Sun Pharmaceuticals 3M Pharmaceuticals
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPEMarket ecosystem Market characteristics Market segmentation analysis
PART 05: PIPELINE ANALYSIS
PART 06: MARKET SIZING
PART 07: FIVE FORCES ANALYSIS
PART 08: MARKET SEGMENTATION BY TYPE OF NMSCSegmentation by type of NMSC Comparison by type of NMSC BCC - Market size and forecast 2017-2022 SCC - Market size and forecast 2017-2022 Market opportunity by type of NMSC
PART 09: MARKET SEGMENTATION BY THERAPY
PART 10: CUSTOMER LANDSCAPE
PART 11: REGIONAL LANDSCAPEGeographical Segmentation Regional comparison Americas - Market size and forecast 2017-2022 EMEA - Market size and forecast 2017-2022 APAC - Market size and forecast 2017-2022 Market opportunity
PART 12: DECISION FRAMEWORK
PART 13: DRIVERS AND CHALLENGES
PART 14: MARKET TRENDSIncreasing incidence of NMSC Surgery considered as a first-line curative approach for NMSC High off-label use of topical treatments for NMSC Low physician adherence to NMSC diagnostic and treatment guidelines
PART 15: VENDOR LANDSCAPE
PART 16: VENDOR ANALYSISVendors covered Vendor classification Market positioning of vendors Bausch Health F. Hoffmann-La Roche Sun Pharmaceuticals 3M Pharmaceuticals
For more information about this report visit https://www.researchandmarkets.com/research/wjv5vf/the_global?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190109005643/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Skin Cancer Drugs
INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 01/09/2019 11:39 AM/DISC: 01/09/2019 11:38 AM